AXIL vs YCBD: stock comparison and AI forecast
Axil Brands, Inc. (AXIL) and Cbdmd, Inc. (YCBD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AXIL Axil Brands, Inc.
- Market Cap
- $35M
- P/E Ratio
- 15.3x
- Size
- small-cap
- AI Forecast
YCBD Cbdmd, Inc.
- Price
- $0.39 -55.4% · 6M
- Market Cap
- $4M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- AXIL is 8.1 times larger than YCBD by market capitalization ($35M against $4M).
- AXIL turns 9.3% of its revenue into net income, against -13.8% for YCBD.
- YCBD carries 0.60 times debt per unit of equity, against 0.34 times for AXIL.
- Both companies share the SEC industry classification Perfumes, Cosmetics & Other Toilet Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AXIL | YCBD |
|---|---|---|
| Market Cap | $35M | $4M |
| P/E Ratio | 15.27x | – |
| P/B Ratio | 2.58x | 0.53x |
| EPS | $0.34 | – |
| Book Value/Share | $2.01 | $0.73 |
| Revenue/Share | $4.41 | $1.87 |
| FCF/Share | $0.64 | $-0.22 |
Profitability & Margins
| Metric | AXIL | YCBD |
|---|---|---|
| ROE | 20.3% | -35.2% |
| ROA | 15.0% | -22.0% |
| ROIC | 21.2% | -28.8% |
| Gross Margin | 72.4% | 57.7% |
| Operating Margin | 10.0% | -13.9% |
| Net Margin | 9.3% | -13.8% |
| EBT Margin | 10.7% | -13.8% |
| Tax Rate | 13.2% | – |
Financial Health
| Metric | AXIL | YCBD |
|---|---|---|
| Current Ratio | 3.31x | 2.50x |
| Quick Ratio | 2.31x | 1.37x |
| D/E Ratio | 0.34x | 0.60x |
| Financial Leverage | 1.35x | 1.60x |
| Interest Coverage | 165.4x | -345.2x |
| Working Capital | $10M | $5M |
Cash Flow
| Metric | AXIL | YCBD |
|---|---|---|
| Operating Cash Flow | $4M | -$2M |
| Free Cash Flow | $4M | -$2M |
| Capital Spending | -$130K | -$190K |
| OCF Growth YoY | 1437.7% | – |
| FCF Growth YoY | 6110.6% | – |
| FCF/Sales | 14.5% | -11.5% |
| CapEx/Sales | 0.4% | 0.9% |
Operational Efficiency
| Metric | AXIL | YCBD |
|---|---|---|
| Asset Turnover | 1.62x | 1.59x |
| Receivables Turnover | 22.7x | 22.6x |
| Inventory Turnover | 1.9x | 2.6x |
| Fixed Assets Turnover | 71.8x | 62.5x |
| Days Sales Outstanding | 16 days | 16 days |
| Days Inventory | 195 days | 143 days |
| Payables Period | 107 days | 61 days |
| Cash Conversion Cycle | 104 days | 97 days |
Income Statement
| Metric | AXIL | YCBD |
|---|---|---|
| Total Revenue | $30M | $21M |
| Operating Income | $3M | -$3M |
| Net Income | $3M | -$3M |
| SG&A Expense | $20M | – |
| Cost of Goods Sold | $8M | $9M |
Dividend & Shareholder Information
| Metric | AXIL | YCBD |
|---|---|---|
| Shares Outstanding | 7M | 11M |
| Net Income Growth | 114.4% | – |
| EPS Growth | 112.5% | – |
AXIL vs YCBD: stock comparison and AI forecast
Which is bigger, AXIL or YCBD?
AXIL is 8.1 times larger than YCBD by market capitalization ($35M against $4M).
Which one does Intratio's AI model rank higher, AXIL or YCBD?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.